NANOVIRICIDES, INC.
About NANOVIRICIDES, INC.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2012
- $0
- Net income
- -$9.5M
- Total assets
- $8.8M
- Market cap
- $31.4M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $9.6M
- Operating income
- -$9.6M
- Net income
- -$9.5M
- EPS (basic)
- $-0.63
- EPS (diluted)
- $-0.63
Balance sheet
- Total assets
- $8.8M
- Current assets
- $1.7M
- Total liabilities
- $1.3M
- Current liabilities
- $1.3M
- Shareholders’ equity
- $7.5M
Cash flow
- Operating cash flow
- -$8.5M
- Investing cash flow
- -$57.0K
- Financing cash flow
- $5.3M
- Net cash flow
- -$3.2M
Statements via Polygon.io (SEC filings)
- Market cap
- $31.4M
- EPS (diluted)
- $-0.63
- Shares outstanding
- 22.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 5, 2005
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $9.5M in FY2012.
- Trading 30% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NANOVIRICIDES, INC..
Write a review
News about NANOVIRICIDES, INC.
News & sentiment via Polygon.io
